Schizophrenia Market Global Scenario, Market Size, Outlook, Trend, and Forecast, 2019 – 2028

TABLE OF CONTENTS

Chapter 1        Prefix

1.1    Market Scope

1.2    Report Description

1.3    Research Methodology

1.3.1     Primary Research

1.3.2     Secondary Research

1.3.3     In-house Data Modeling

Chapter 2        Executive Summary

2.1   Global Schizophrenia Market Year-on-Year Growth, 2020 – 2028 (%)

Chapter 3        Market Outline

3.1    Market Inclination, Trend, Outlook, and Viewpoint

3.2    Market Share Analysis: Company’s Competitive Scenario

3.3    Value Chain Analysis

3.4    Porter’s Five Forces Analysis

3.5    Market Dynamics

3.5.1     Drivers

3.5.1.1     Impact Analysis

3.5.2     Restraints

3.5.2.1     Impact Analysis

3.5.3     Opportunities

Chapter 4        Global Schizophrenia Market by Type: Market Size and Forecast, 2019 - 2028

4.1  Overview

4.2  Paranoid Schizophrenia

4.2.1   Current Trend and Analysis

4.2.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

4.2.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

4.3  Hebephrenic Schizophrenia

4.3.1   Current Trend and Analysis

4.3.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

4.3.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

4.4  Catatonic Schizophrenia

4.4.1   Current Trend and Analysis

4.4.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

4.4.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

4.5  Undifferentiated Schizophrenia

4.5.1   Current Trend and Analysis

4.5.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

4.5.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

Chapter 5        Global Schizophrenia Market by Treatment: Market Size and Forecast, 2019 – 2028

5.1  Overview

5.2  Second-Generation Antipsychotics

5.2.1   Current Trend and Analysis

5.2.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

5.2.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

5.2.4   Risperdal (Risperidone)

5.2.5   Invega (Paliperidone)

5.2.6   Zyprexa (Olanzapine)

5.2.7   Geodon (Ziprasidone)

5.2.8   Seroquel (Quetiapine)

5.2.9   Latuda (Lurasidone)

5.3  Third-Generation Antipsychotics

5.3.1   Current Trend and Analysis

5.3.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

5.3.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

Chapter 6    Global Schizophrenia Market by Route Of Administration: Market Size and Forecast, 2019 – 2028

6.1  Overview

6.2  Oral

6.2.1   Current Trend and Analysis

6.2.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

6.2.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

6.3  Injectables

6.3.1   Current Trend and Analysis

6.3.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

6.3.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

Chapter 7        Global Schizophrenia Market by Geography: Market Size and Forecast, 2019 - 2028   

7.1  Overview

7.1.1   Global Schizophrenia Market Year-on-Year Growth, by region 2020 – 2028 (%)

7.2  North America

7.2.1   Current Trend and Analysis

7.2.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

7.2.3   U.S.

7.2.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.2.3.2        By Type

7.2.3.3        By Treatment

7.2.3.4        By Route Of Administration

7.2.4   Canada

7.2.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.2.4.2        By Type

7.2.4.3        By Treatment

7.2.4.4        By Route Of Administration

7.2.5   Mexico

7.2.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.2.5.2        By Type

7.2.5.3        By Treatment

7.2.5.4        By Route Of Administration

7.3      Europe

7.3.1   Current Trend and Analysis

7.3.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

7.3.3   UK

7.3.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.3.3.2        By Type

7.3.3.3        By Treatment

7.3.3.4        By Route Of Administration

7.3.4   Russia

7.3.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.3.4.2        By Type

7.3.4.3        By Treatment

7.3.4.4        By Route Of Administration

7.3.5   France

7.3.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.3.5.2        By Type

7.3.5.3        By Treatment

7.3.5.4        By Route Of Administration

7.3.6   Italy

7.3.6.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.3.6.2        By Type

7.3.6.3        By Treatment

7.3.6.4        By Route Of Administration

7.3.7   Germany

7.3.7.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.3.7.2        By Type

7.3.7.3        By Treatment

7.3.7.4        By Route Of Administration

7.3.8   Rest of Europe

7.3.8.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.3.8.2        By Type

7.3.8.3        By Treatment

7.3.8.4        By Route Of Administration

7.4    Asia-Pacific

7.4.1   Current Trend and Analysis

7.4.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

7.4.3   China

7.4.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.4.3.2        By Type

7.4.3.3        By Treatment

7.4.3.4        By Route Of Administration

7.4.4   India

7.4.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.4.4.2        By Type

7.4.4.3        By Treatment

7.4.4.4        By Route Of Administration

7.4.5   Japan

7.4.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.4.5.2        By Type

7.4.5.3        By Treatment

7.4.5.4        By Route Of Administration

7.4.6   Rest of Asia-Pacific

7.4.6.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.4.6.2        By Type

7.4.6.3        By Treatment

7.4.6.4        By Route Of Administration

7.5    RoW

7.5.1   Current Trend and Analysis

7.5.2   Market Size and Forecast

7.5.3   South America

7.5.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.5.3.2        By Type

7.5.3.3        By Treatment

7.5.3.4        By Route Of Administration

7.5.4   Middle East

7.5.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.5.4.2        By Type

7.5.4.3        By Treatment

7.5.4.4        By Route Of Administration

7.5.5   Africa

7.5.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.5.5.2        By Type

7.5.5.3        By Treatment

7.5.5.4        By Route Of Administration         

Chapter 8        Company Profiles

8.1  Johnson & Johnson.

8.1.1     Company Overview

8.1.2     Product Portfolio

8.1.3     Business Strategies

8.1.4     Financials

8.1.5     Recent Developments

8.2  Bristol-Myers Squibb and Company.

8.2.1     Company Overview

8.2.2     Product Portfolio

8.2.3     Business Strategies

8.2.4     Financials

8.2.5     Recent Developments

8.3  Otsuka Pharmaceuticals.

8.3.1     Company Overview

8.3.2     Product Portfolio

8.3.3     Business Strategies

8.3.4     Financials

8.3.5     Recent Developments

8.4  AstraZeneca.

8.4.1     Company Overview

8.4.2     Product Portfolio

8.4.3     Business Strategies

8.4.4     Financials

8.4.5     Recent Developments

8.5  Eli Lilly.

8.5.1     Company Overview

8.5.2     Product Portfolio

8.5.3     Business Strategies

8.5.4     Financials

8.5.5     Recent Developments

8.6  Alkermes.

8.6.1     Company Overview

8.6.2     Product Portfolio

8.6.3     Business Strategies

8.6.4     Financials

8.6.5     Recent Developments

8.7  Allergan.

8.7.1     Company Overview

8.7.2     Product Portfolio

8.7.3     Business Strategies

8.7.4     Financials

8.7.5     Recent Developments

8.8  Pfizer.

8.8.1     Company Overview

8.8.2     Product Portfolio

8.8.3     Business Strategies

8.8.4     Financials

8.8.5     Recent Developments

8.9  Vanda Pharmaceuticals.

8.9.1     Company Overview

8.9.2     Product Portfolio

8.9.3     Business Strategies

8.9.4     Financials

8.9.5     Recent Developments

8.10 Sumitomo Dainippon Pharma.

8.10.1   Company Overview

8.10.2   Product Portfolio

8.10.3   Business Strategies

8.10.4   Financials

8.10.5   Recent Developments

8.11 Others.

8.11.1   Company Overview

8.11.2   Product Portfolio

8.11.3   Business Strategies

8.11.4   Financials

8.11.5   Recent Developments